GB2147579A - Production of L-amino acids from alpha-keto acids by fermentation - Google Patents
Production of L-amino acids from alpha-keto acids by fermentation Download PDFInfo
- Publication number
- GB2147579A GB2147579A GB08419142A GB8419142A GB2147579A GB 2147579 A GB2147579 A GB 2147579A GB 08419142 A GB08419142 A GB 08419142A GB 8419142 A GB8419142 A GB 8419142A GB 2147579 A GB2147579 A GB 2147579A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- alpha
- keto
- culture
- microorganisms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000004716 alpha keto acids Chemical class 0.000 title claims abstract description 58
- 150000008575 L-amino acids Chemical class 0.000 title claims abstract description 38
- 238000000855 fermentation Methods 0.000 title description 12
- 230000004151 fermentation Effects 0.000 title description 12
- 238000004519 manufacturing process Methods 0.000 title description 10
- 244000005700 microbiome Species 0.000 claims abstract description 41
- 238000005891 transamination reaction Methods 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 10
- 102000004190 Enzymes Human genes 0.000 claims abstract description 10
- 241000186216 Corynebacterium Species 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 40
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 claims description 23
- 239000002609 medium Substances 0.000 claims description 20
- 239000001963 growth medium Substances 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 13
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims description 12
- 239000002243 precursor Substances 0.000 claims description 11
- QHKABHOOEWYVLI-UHFFFAOYSA-N 3-methyl-2-oxobutanoic acid Chemical compound CC(C)C(=O)C(O)=O QHKABHOOEWYVLI-UHFFFAOYSA-N 0.000 claims description 10
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 10
- 239000004220 glutamic acid Substances 0.000 claims description 10
- 235000013922 glutamic acid Nutrition 0.000 claims description 10
- 235000015097 nutrients Nutrition 0.000 claims description 10
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 claims description 9
- QUKRTJQSGPLQKQ-UHFFFAOYSA-N 5-methylsulfonyl-3h-1,3-benzoxazol-2-one Chemical compound CS(=O)(=O)C1=CC=C2OC(=O)NC2=C1 QUKRTJQSGPLQKQ-UHFFFAOYSA-N 0.000 claims description 8
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 229940107700 pyruvic acid Drugs 0.000 claims description 6
- 230000003698 anagen phase Effects 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- RSTKLPZEZYGQPY-UHFFFAOYSA-N 3-(indol-3-yl)pyruvic acid Chemical compound C1=CC=C2C(CC(=O)C(=O)O)=CNC2=C1 RSTKLPZEZYGQPY-UHFFFAOYSA-N 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 18
- 241000186146 Brevibacterium Species 0.000 abstract description 8
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 29
- 230000012010 growth Effects 0.000 description 24
- 239000011734 sodium Substances 0.000 description 22
- 238000011218 seed culture Methods 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
- 239000008103 glucose Substances 0.000 description 17
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 17
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 16
- 239000008367 deionised water Substances 0.000 description 15
- 229910021641 deionized water Inorganic materials 0.000 description 15
- 229960005190 phenylalanine Drugs 0.000 description 15
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 12
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 11
- 239000011148 porous material Substances 0.000 description 10
- 229910001868 water Inorganic materials 0.000 description 10
- 241000186226 Corynebacterium glutamicum Species 0.000 description 9
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 229960000583 acetic acid Drugs 0.000 description 8
- 238000012807 shake-flask culturing Methods 0.000 description 8
- UDTSPKADQGPZFS-SOFGYWHQSA-N (5e)-5-benzylideneimidazolidine-2,4-dione Chemical compound N1C(=O)NC(=O)\C1=C/C1=CC=CC=C1 UDTSPKADQGPZFS-SOFGYWHQSA-N 0.000 description 7
- UDTSPKADQGPZFS-UHFFFAOYSA-N 1/7/3775 Natural products N1C(=O)NC(=O)C1=CC1=CC=CC=C1 UDTSPKADQGPZFS-UHFFFAOYSA-N 0.000 description 7
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 238000006911 enzymatic reaction Methods 0.000 description 7
- 229950006238 nadide Drugs 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 6
- 230000036983 biotransformation Effects 0.000 description 6
- 239000012362 glacial acetic acid Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229960004295 valine Drugs 0.000 description 6
- 238000010268 HPLC based assay Methods 0.000 description 5
- 239000007993 MOPS buffer Substances 0.000 description 5
- -1 ammonium ions Chemical class 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 239000005515 coenzyme Substances 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 239000004395 L-leucine Substances 0.000 description 4
- 235000019454 L-leucine Nutrition 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 229960003136 leucine Drugs 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 101710088194 Dehydrogenase Proteins 0.000 description 3
- 229930195714 L-glutamate Natural products 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- UZVNBCKXIIHMIH-UHFFFAOYSA-N 2-oxo-3-phenylpropanoic acid;sodium Chemical compound [Na].OC(=O)C(=O)CC1=CC=CC=C1 UZVNBCKXIIHMIH-UHFFFAOYSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 2
- FKEBJFWQLNFBHG-UHFFFAOYSA-N 5-(2-methylpropylidene)imidazolidine-2,4-dione Chemical compound CC(C)C=C1NC(=O)NC1=O FKEBJFWQLNFBHG-UHFFFAOYSA-N 0.000 description 2
- GHKHZJHMIBYCPG-UHFFFAOYSA-N 5-propan-2-ylideneimidazolidine-2,4-dione Chemical compound CC(C)=C1NC(=O)NC1=O GHKHZJHMIBYCPG-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 2
- 241001131785 Escherichia coli HB101 Species 0.000 description 2
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 229930182844 L-isoleucine Natural products 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LBIHGNOIDXKJKU-UHFFFAOYSA-N O.C1(=CC=CC=C1)CC(C(=O)O)=O Chemical compound O.C1(=CC=CC=C1)CC(C(=O)O)=O LBIHGNOIDXKJKU-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 229940068840 d-biotin Drugs 0.000 description 2
- 238000007357 dehydrogenase reaction Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- VADRPUHKHSPFTJ-QRPNPIFTSA-N (2s)-2-amino-3-phenylpropanoic acid;2-oxo-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)C(=O)CC1=CC=CC=C1 VADRPUHKHSPFTJ-QRPNPIFTSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- BKAJNAXTPSGJCU-UHFFFAOYSA-N 4-methyl-2-oxopentanoic acid Chemical compound CC(C)CC(=O)C(O)=O BKAJNAXTPSGJCU-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N Valeric acid Natural products CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000003424 hydrogenase reaction Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- MQGYVGKMCRDEAF-UHFFFAOYSA-M sodium;2-oxo-3-phenylpropanoate Chemical compound [Na+].[O-]C(=O)C(=O)CC1=CC=CC=C1 MQGYVGKMCRDEAF-UHFFFAOYSA-M 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C12P13/222—Phenylalanine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
L-amino acids are prepared by contacting a logarithmically growing culture of suitable microorganisms e.g. a brevibacterium, corynebacterium or E. Coli with the corresponding alpha-keto acids. The conversion of alpha-keto acid to L-amino acid takes place via a transamination reaction driven by a coupled enzyme system which is provided by the growing culture.
Description
SPECIFICATION
Production of L-amino acids from alpha-keto acids
This invention relates generally to the biological production of L-amino acids. More specifically, it has been found that an L-amino acid may be prepared from its corresponding alpha-keto acid precursor by feeding the aipha-keto acid to an actively, logarithmically growing culture of a suitable microorganism in a nutrient medium. There are numerous microorganisms capable of the biotransformation of alpha-keto acids to L-amino acids.
It is known that alpha-keto acids may be converted enzymatically into their corresponding Lamino acids. For example, U.S. 2,749,279 discloses a process wherein alpha-ketoglutaric acid and ammonia are treated with a biological enzyme-coenzyme catalyst. Suitable biological catalysts may be obtained from animal tissue, from rapidly growing plants or from bacteria in the form of autolysates or extracts of the cell culture. Similarly, U.S. 4,304,858 discloses the conversion of water soluble alpha-ketocarboxylic acids to the corresponding amino acids in the presence of a substrate specific dehydrogenase, ammonium ions, and nicotinamide-adeninedinucleotide (NAD + /NADH). Transformation of aipha-keto acids to amino acids using restingcell suspensions has been reported by Yamada et al., The Production of Amino Acids, pp.
440-46 (1972).
SUMMARY OF THE INVENTION
It now has been found that biotransformation of an alpha-keto acid to the corresponding Lamino acid can be mediated more efficiently by an actively growing culture of microorganisms.
Microorganisms capable of transforming alpha-keto acids into L-amino acids are grown in a nutrient medium. The alpha-keto acid precursor of the desired L-amino acid is fed to the actively, logarithmically growing culture. The transamination reaction is driven substantially to completion by a coupled enzymatic system provided by the microorganisms of the growing culture, allowing for continuous recycling of the amino donor (L-glutamate) and the coenzyme (NADH or NADPH). The L-amino acid may be recovered from the culture broth.
It is a primary object of this invention to provide a highly efficient process for the biological transamination of alpha-keto acids to their corresponding L-amino acids.
Moreover, it is intended that the process of this invention be useful with a broad range of microorganisms and for production of a broad range of L-amino acids.
It is an additional object to provide a process in which a single strain of microorganisms can produce sufficient quantities of all required enzymes to convert a given alpha-keto acid to Lamino acid.
A further object is to provide for a high level of alpha-keto acid conversion to L-amino acid over a short reaction period.
A still further object is to provide a method which produces a high yield of L-amino acids in the presence of a low concentration of the amino donor.
DESCRIPTION OF THE INVENTION
Bacterial growth generally may be divided into three sequential phases. The lag growth phase is a period in which there is littie or no increase in the number of microorganisms in the culture.
In the logarithmic or exponential growth phase, the number of cells increases exponentially over time. In the stationary phase, there is iittle or no cellular growth or division.
It has been found that the microbial transamination of an alpha-keto acid to L-amino acid can be conducted with increased efficiency by adding the alpha-keto acid to a logarithmically growing culture of suitable microorganisms. Fed-batch fermentation according to the method of this invention results in high yields at high conversion rates. This process takes advantage of a coupled enzyme system present in the growing microorganisms to drive the reaction to completion. The L-amino acid product may be recovered from the culture broth.
The Reaction
The alpha-keto acid to L-amino acid biotransformation is an enzymatic transamination reaction
The biotransformation is mediated by a coupled enzyme-coenzyme system comprising a transaminase. a glutamate dehydrogenase, the coenzyme NADP + /NADPH (or NAD + /NADH), and a dehydrogenase. Alternatively, the latter component of the enzyme system may be an hydrogenase for the recycling of NADP + (or NAD +) back to NADPI-1 (or NADH).
The coupled reaction system may be depicted graphically as follows:
(NADPH) or L-amino (NADH) a-ketoglutarate acid (hydro-) i J i J < genasej or --- -- gluta- --trans- Iluta- ase hy dro- dehydro genase genase 8 t 8 f (NADP ) L-glutamate a-keto or acid (NAD+) (3) (2) (1) The desired transamination reaction (step (1)), alpha-keto acid to L-amino acid, normally is reversible and would go merely to equilibrium, thus limiting the efficiency of the conversion to the amino acid.By coupling the transamination reaction to other enzymatic reactions. the transamination theoretically may be driven to completion. although chemical degradation reactions may be present which will decrease the actual yield.
The coupled enzymatic reaction designated as step (2) above, recycles one of the transamination products, alpha-ketoglutarate, back to L-glutamate. This step, a reductive amination, is mediated by glutamate dehydrogenase and requires the presence of ammonium ions. The Lglutamate available for the transamination of the alpha-keto acid to the L-amino acid is continuously replaced by this recycle step.
Step (2) utilizes one of the coenzymes NADPH or NADH, which is converted to NADP + or
NAD +. A third enzymatic reaction, step (3), converts this NADP + (NAD +) product back into
NADPH (NADH) via either a dehydrogenase reaction or an hydrogenase reaction. Thus, the
NADPH (NADH) required for step (2) also is continuously replenished. The NH4 + required for step (2) is supplied in the nutrient medium.
The enzymatic reaction system itself is known. However, prior uses of this system have required the addition of three different microorganisms to supply the reaction components of the three steps depicted above, U.S. 3,183,170 (Kitai et al.) or the addition of microorganisms, amino donors and cofactor (Yamada et al. The Microbial Production of Amino Acids, pp.
440-46 (1976)). Moreover, these prior methods use resting cell suspensions.
The invention disclosed herein utilizes a single microorganism strain to provide the entire coupled enzymatic reaction system. A logarithmically growing culture of suitable microorganisms, with the provision of ammonium ions in the culture medium, will mediate all three steps of the biotransformation of alpha-keto acids to their respective L-amino acids. In the method of this invention, step (3) in the coupled enzyme system utilizes a dehydrogenase reaction for converting NADP + (NAD +) to NADPH (NADH).
The Reactants
The coupled enzymatic reaction system is present in actively growing microorganisms. This naturally occurring system now can be utilized for the efficient conversion of alpha-keto acids to
L-amino acids. By providing suitable microorganisms with the proper substrate, the conversion is carried out in high yields by the microorganisms themselves.
The types of microorganisms suitable for use in this bioconversion process are considerably varied. For example, bacterial strains known to be glutamic acid producers have been utilized with success. These include Brevibacterium thiogenitalis (ATCC No. 31723), Brevibacterium lactofermentum (ATCC No. 1 3655), Brevibacterium ammoniagenes (ATCC No. 13746), Brevibacterium glutamigenes (ATCC No. 13747), Brevibacterium flavum (ATCC No. 13826) and
Corynebacterium hercules (ATCC No. 13868). The ATCC No. indicated is the designation number given each culture by the American Type Culture Collection, 1 2301 Parklawn Drive,
Rockville, Maryland 30852, where each of the above cultures has been deposited. It is expected that other glutamic acid producers also will be suitable for use with this process.
In addition, it has been found that E. coli HB101, not normally considered a glutamic acid producer, may be used in this process with yields equivalent to the above-mentioned microorganisms. E. coli is not a glutamic acid producer in the sense that it does not excrete glutamic acid into the medium. However, all microorganisms produce small intracellular amounts of the substance. The enzyme system of interest here requires only catalytic amounts of glutamic acid to start the reaction and E. Coliappears to generate sufficient amounts of glutamic acid to complete step (2) of the coupled system.
It is apparent that there is a wide variety of microorganisms useful in this bioconversion process. The primary requirement is that the microorganism be capable of absorbing and converting an alpha-keto acid to the corresponding L-amino acid. In order to most efficiently carry out the bioconversion, the microorganism should be capable of producing sufficient quantities of the enzymes involved in steps (1) through (3) of the coupled enzyme system to drive the transamination reaction beyond the equilibrium point substantially towards completion.
Finally, the microorganism preferably should be capable of excreting the L-amino acid into the culture medium for convenient and economical recovery.
The alpha-keto acid selected for use with this process will depend upon which L-amino acid is the desired product. For example, phenylpyruvic acid is converted to L-phenylalanine, alphaketoisocaproic acid to L-leucine, alpha-ketoisovaleric acid to to L-valine, pyruvic acid to L-alanine, oxaloacetic acid to L-aspartic acid, ss-hydroxy-aípha-ketobutyric acid to L-threonine, p-o.yphenyl pyruvic acid to L-tyrosine, indole pyruvic acid to L-tryptophan, alpha-keto-P-methyl valeric acid to L-isoleucine, etc. As can be seen, conventional L-amino acid precursors are used in the inventive process.
It is preferred that the alpha-keto acid be added to the culture in aqueous solution as this form facilitates pumping the precursor into the culture broth. However, it desired, the alpha-keto acid may be in other physical forms, such as a solid or slurry.
The purity of the alpha-keto acid precursor has been shown to affect the L-amino acid yield rather dramatically, at least in the case of the conversion of phenylpyruvate to phenylalanine (see Example 5). In adition to the increased amounts of alpha-keto acid available in purified precursor, it is believed that the microorganisms may display less sensitivity to the purified alpha-keto acid.
The concentration of the aqueous solution of alpha-keto acid, if that is the form in which it is fed to the culture, may vary considerably. For example, if this invention is used in a continuous fermentation, the solution would be more dilute than for batch fermentation. The upper limit on concentration may depend on the solubility of the alpha-keto acid in the desired solvent. It is expected that levels of about 1.0 to 200 gm/l may be suitable, with the concentration depending on the particular alpha-keto acid, as well as on the factors discussed above. The alpha-keto acid most conveniently is dissolved in water but other solvents compatible with the fermentation, additional growth medium, for example, may be used if desired.
The nutrient medium should be chosen to provide optimal growth conditions for the microorganism used. Media variation and adjustment is well within the capability of persons skilled in this art and need not be discussed in detail here.
In addition to the basic nutritional requirements, however, the medium should contain a source of NH + . The ammonium ions are used by the microorganisms both to increase cell mass and for step (2) of the coupled enzymatic reaction system. Thus, the levels of ammonium ion in the culture medium should be geared to the desired production of amino acid and cell mass. This adjustment of NH4 + level also is well known to persons skilled in this art. As an example, the ions conveniently may be supplied by adding to the nutrient medium ammonium sulfate in a concentration of about 10 to about 50 gm/l. Alternatively, urea, ammonium chloride, ammonium nitrate, ammonium acetate, etc. may be used as the NH4 + donor.
The Reaction Process
The bioconversion process of this invention requires a culture of actively growing microorganisms. This culture may be prepared by inoculating a quantity of sterile nutrient or growth medium with a seed culture of the desired strain. The seed culture used to inoculate the nutrient medium preferrably is allowed to grow for about 6 to 40 hours prior to use as inoculum. The length of time for growing the seed culture prior to inoculation will vary depending on the bacterial strain used. It is desired that the seed culture comprise a healthy, growing cell mass sufficient to form a good basis for establishment and growth of the fermentation culture.
The size of the fermentation reactor will depend on the specific application of this process. It is well within the knowledge of those skilled in the art to adjust the quantities of medium and seed culture to the requirements of a specific reactor or desired yield.
The culture is allowed to grow in the fermentation reactor until the culture has become acclimated to the reactor environment and has grown to a cell mass sufficient to withstand addition of the alpha-keto acid. This is particularly important when impure precursor is used.
Optical density may be a convenient measure of cell growth. An optical density ("O.D.") (640 nm) of approximately 10 generally indicates that the culture is ready for the addition of the alpha-keto acid. This corresponds to a growth period of approximately 6-40 hours, depending on the organism and growth conditions. However, this may be somewhat variable and should not be viewed as a strict requirement, but rather left to the experience and discretion of the worker.
The culture is grown at a temperature compatible with maximal growth of the bacterial strain used. The general range will be from ambient temperatures up to about 37 C. For Corynebac
teria and Brevibacterium. the preferred temperature is about 30"C; for E. Coli. the preferred temperature is about 37 C. The pH of the culture preferably should be about 7-8. Aeration may be provided if necessary for the bacterial strain selected.
At this stage, the reactor is fed with the desired alpha-keto acid. The alpha-keto acid preferably is in an aqueous solution as described above. The alpha-keto acid concentration in this aqueous solution may be from about 1.0% to about 20% (wt/wt). The solution pH may be from about 7 to about 14. The pH may be adjusted to lower pHs with glacial acetic acid or other biologically compatible acids (such as sulfuric acid or citric acid) or with gaseous carbon dioxide. The solution may be sterilized by steam (e.g., at 121 C for 15 minutes). Milli-pore filtration (e.g., 0.22 iz pore size) or by other convenient means.
If necessary for continued culture growth. a sterile glucose solution may be fed into the fermentor with or at about the same time as the alpha-keto acid. However, excess glucose remaining in the culture broth at the end of the fermentation may interfere with the recovery of the amino acid product. If that occurs, the quantity of glucose provided to the culture should be iimited to the amount calculated to be utilized by the cell mass during fermentation.
The addition of alpha-keto acid (and glucose, if desired) preferably is made aseptically to avoid c:nt,,minating the reactor. The reactor culture broth concentration of the alpha-keto acid probably will be in the range of about 20 gm/l to about 50 gm/l for a slug fed batch reactor.
For continuous fermentation, the concentration may be lower. However. it is desired to have the alpha-keto acid concentration as high as possible, without disrupting metabolism, in order to maximize its utilization by the microorganisms during the logarithmic growth phase.
The culture then is allowed to grow for an additional period, preferably about 20 to about 72 hours. This period, during which the alpha-keto acid Is biotransformed into the L-amino acid.
preferably is as short as possible, while still allowing for maximum yields. By the process of this invention, maximum expected yields may be as high as 100% in as short a period as 23 hours, as shown for the production of L-phenylalanine in Example 6. After the growth period, the Lamino acid product may be recovered from the culture broth by conventional means.
The following Examples are given for illustrative purposes only and are not meant to limit the invention described herein.
Example 1
The following seed culture media were prepared: Seed 1 Ingredients Growth1 30.00 gm Glucose2 100.00 gm 2.50 gm Corn steep liquor 2.50 gm 2.50 gm NZ Amine B 2.50 gm 1.00 gm SzHPO4 1.00 gm 0.25 gm MgSO4.7H2O 0.25 gm 10.00 gm (NH4)2So4 3 50.00 gm 1.00 cc Biotin stock solution 1.00 cc
1.00 cc Thiamine-HCl stock solution4 1.00 cc
20.90 gm MOPS buffer5 20.90 gm 1 - Per liter deionized water.
2 - A 70t (wt/vol) glucose stock solution.
3 - 100 mg d-biotin per liter deionized water.
4 - 1.0 gm thiainine-HCl per liter deionized water.
5 - MOPS = morpholinopropane-sulfonic acid.
All ingredients except for the glucose were combined and steam sterilized at 121 do for 15 minutes. The glucose solution was sterilized separately by the same method and then added aseptically to the rest of the media. Flasks (250 cc) of seed culture medium were used to grow two seed cultures for each of six glutamic acid-producing bacterial strains.The strains and the optical densities for each strain after the seed cultures were allowed to grow for 8 hours are as follows:
Strain Optical Density (640nm)
Brevibacterium 3.9 + 0.1
thiogenitalis (ATCC 31723)
Brevibacterium 11.2 + 0.8
lactofermentum (ATCC 13655)
Brevibacterium 6.0 + 0.4
ammoniagenes (ATCC 13746)
Brevibacterium 9.2 + 0.2
glutamigenes (ATCC 13747)
Brevibacterium 13.3 + 0.3 flavum (ATCC 13826)
Corynebacterium 12.3 + 0.7
hercules (ATCC 13868)
The sterilized growth medium was added in 50 cc aliquots to 250 cc indented shake flasks.
Each flask was inoculated with a single seed culture on a 1 % vol/vol basis. The shake flask cultures were allowed to grow at 300 RPM shaking speed for 1 7 hours at 30"C for both the
Brevibacterium and the Corynebacterium cultures.
An aqueous sodium phenylpyruvic acid (Na-PPA) solution was used. The solution was an unpurified sodium hydroxide hydrolyzate of 5-benzylidenehydantoin. Preparation of the hydrolyzate of the 5-benzylidenehydantoin (Hamsphire Chemical Co.) was according to the following procedure: 2233 gm deionized water and 223.3 gm NaOH were combined in a 3 liter stainless steel beaker and heated to boiling. While continuing to boil, 350 gm 5-benzylidenehydantoin was added slowly. Boiling was continued at 101-103"C for 2 hours. The solution was mixed during the reaction with an electric mixer. After boiling, the mixture was cooled down quickly in an ice water bath. The final volume of this hydrolyzate was 1,810 ml, with a Na-PPA-N20 concentration of 162 gm/l, a pH of 13.51 and a color of clear amber.A one molar solution of the sodium phenylpyruvate (hydrolyzate) 1.2M NaOH, 0.5M sodium carbonate and 0.5M urea.
The Ph of the solution was adjusted to 8 using 2N acetic acid and was then sterilized using a
Milli-pore filter (0.22 it pore size).
A separate glucose solution (70% wt/vol in deionized water) was prepared and was steam sterilized at 121 C for 1 5 minutes. The glucose solution was added aseptically to the sterile Na
PPA solution at a volumetric ratio of 3:7. A volume of the composite solution was added to each shake flask so that a 10 gm/l Na phenylpyruvate concentration in the culture broth was achieved.
Each shake flask culture was allowed to grow for an additional 23 hours, for a total growth period of 40 hours. At that time, broth samples were removed and assayed for L-phenylalanine using a high pressure liquid chromatograph (HPLC) system. Milli-pore filtered (0.22 IL pore size) broth samples were derivatized using a Dansylchloride technique prior to injection onto the
HPLC.
Dry cell weights also were determined for each broth sample. A 10 cc sample of broth from each flask was centrifuged at 10,000 RPM for 30 minutes. The wet cell paste was dried in an oven at 80"C for 24 hours, followed by 1 5 minutes in a vacuum dessicator. The dry cell sample then was weighed.
For each shake flask, the average rate of L-phenylalanine production over the 23 hour period was calculated per gram dry weight of cell mass. The test results for duplicate shake flasks for each strain of microorganism are shown in Table Table 1
Dry Cell % Conversion
Microorganism Wt. (gm/l) mM (gm/l) L-phenylalanine (mole/mole) Average Rate
ATCC #31723 39 # 0.8 40.9 # 1.0 (6.8 # 0.2) 67 # 1.5 45.6 # 1.9
ATCC #13655 22.4 # 3.2 25.7 # 4.5 (4.3 # 0.8) 42.3 # 7.5 49.6 # 1.7
ATCC #13746 34.7 # 0.6 28.2 # 0.3 (4.65 # 0.05) 46.2 # 0.5 35.3 # 0.2
ATCC #13747 46.5 # 12.6 29.4 # 1.5 (4.9 # 0.3) 48.2 # 2.5 39 # 9.6
ATCC #13826 51.6 # 5.1 41.2 # 7.9 (6.8 # 1.3) 67.6 # 12.9 34.4 # 3.2
ATCC #13868 42.5 # 1.5 38.4 # 2.1 (6.4 # 0.4) 63.1 # 3.5 39.3 # 0.8 1-M L-phenylalanine produced/hour/gm dry cell weight.
Example 2
The following culture medium (luria broth) was prepared:
Ingredient Quantity
Bacto-Tryptone 10.0 gm
Bacto-Yeast Extract2 5.0 gm NaCl 3 5.0 gm MOPS buffer 20.9 gm 1 - Per liter deionized water.
2 - Available from Difco.
3 - MOPS = inorpholinopropane-sulfonic acid.
The ingredients were combined and were steam sterilized at 121 C for 15 minutes. The sterilized medium was added in 50 cc aliquots to 250 cc indented shake flasks. Each shake flask was inoculated with a culture of Escherichia coli HB 101 on a 1% (vol/vol) basis.
Th cultures in the flasks were allowed to grow for 8 hours at 37 C and 300 RPM shaking speed for use as seed cultures. At the end of this period the optical density (640nm) was 6.27 i 0.03 for the duplicte shake flask experiments. This seed culture then was used to inoculate fresh 250 cc shake flasks, which were allowed to grow 17 hours before being fed with the alpha-keto acid.
A sterile aqueous Na phenylpyruvic acid-glucose solution was prepared as in Example 1. This solution was fed to the test shake flask cultures at the end of the 17 hour growth period (optical density = 10.3 # 1.3), as in Example 1, to achieve a final broth Na phenylpyruvic acid of 10 gm/l. After an additional 23 hours of growth, samples were removed and dry cell weights and
L-phenylalanine concentrates determined as in Example 1. The results are shown in Table 2. Table 2
Dry Cell % Conversion
Wt. (gm/l) mM (gm/l) L-phenylalanine (mole/mole) Average Rate 19.4 # 0.3 31.8 # 5.8 (5.3 # 1.0) 52.2 # 9.5 71.3 # 13.8 1- M L-phenylalanine produced/hour/gm dry cell weight.
Example 3
The following seed culture medium was prepared:
Ingredients Quantity
Hysoy I 3.0 gm L-Isoleucine 1.0 gm MgSO4'7H2O 0.4 gm (NH4)2S04 10.0 gm KH2PO4 3.0 gm Trace elements2 1.0 cc
CaCO3 15.0 gm Biotin stock solution3 1.0 cc Thiainine-HCl stock solution4 1.0 cc
Deionized water 700.0 cc
1 - available from Sheffield Co.
2 - Trace element stock solution consisted of:
Ingredient Quantity
ZnSO4 . 7H2O 8.8 gm
FeSO4 . 7H2O 10.0 gm
CuSO4 . 5H2O 0.06 gm Na2B4O 10H20 0.088 gin Na Mo 4 .2H20 0.053 gm MnSO4 . H2O 7.5 gm
CoCl2 . 6H2O 0.12 gm CaC12 0.055 gm Deionized water 900.00 cc
The trace element stock solution was adjusted to pH 2
with concentrated H2SO4 and deionized water added to
bring the final volume to 1000 cc.
3 - 100 mg d-biotin per liter deionized water.
4 - 1.0 gm thiainine-HCl per liter deionized water.
The above medium was adjusted to pH 7.5 with 5N NaOH, and deionized water added to bring the volume to 900 cc. The medium was steam sterilized at 121 for 15 minutes. A stock solution glucose (50 gm/100 cc deionized water) was steam sterilized separately at 121 C for 15 minutes. After cooling, the sterile glucose was added aseptically to the sterile medium to bring the final medium volume to 1000 cc. The pH was adjusted to 7 with 5 N glacial acetic acid.
Fifty cc aliquots of the seed culture medium were added to each of two 250 cc indented shake flasks. The flasks were inoculated with Brevibacterium thiogenitalis ATCC No. 31723 and grown for 8 hours at 30 C with shaking (300 RPM shaking speed) to form seed cultures. At the end of the 8 hours growth, the optical density (640nm) was about 10.0.
Growth medium was prepared in the same manner as the seed medium, except that 50 gm of (NH4)2SO4 was used. Fifty cc aliquots of the growth medium were distributed to two 250 cc indented shake flasks. The flasks then each were inoculated with a 2.5 cc sample from one of the seed cultures. After inoculation, the shake flask cultures were grown for 33 hours at 30 C with shaking (300 RPM).
A sterile glucose solution (70% wt/vol in deionized water) was prepared as in Example 1. An aqueous unpurified 17.5% (wt/wt) solution of Na alpha-ketoisocaproic acid (density = 1.125 gm/cc; pH = 13.5) was used. The solution was a sodium hydroxide hydrolyzate of isobutylidenehydantoin prepared according to the method described in Example 1 using a sufficient quantity of the isobutylidenehydantoin to form a 15% solution in water and NaOH prior to boiling. A one molar solution of the Na alpha-ketoisocaproic acid (hydrolyzate) contained about 1.2M NaOH, 0.5M sodium carbonate and 0.5M urea. The Na alpha-ketoisocaproic acid solution was adjusted to pH 7 with concentrated glacial acetic acid, and steam sterilized at 121 C for 15 minutes. Equal volumes of the sterile glucose solution and sterile Na alpha-ketoisocaproic acid solution were mixed aseptically and the pH readjusted to 7 with glacial acetic acid.
Volumes of the combined solution were added to the shake flask cultures so that the final broth concentrations of alpha-ketoisocaproic acid were as shown in Table 3. The cultures were allowed to grow for an additional 62 hours. After this growth period, samples were taken, Milli pore filtered (0.22 IL pore size) to remove the cells, and analyzed for L-leucine using a high pressure liquid chromatograph (HPLC) assay as described in Example 1. The results are shown in Table 3.
Table 3
Na c-Ketoisocaproic Molar Acidl L-Leucine Produced2 Yield3 0.03l2M (4.10 gum/1) 0.025M (3.28 gm/l) 80.0%
0.0354M (4.61 gm/l) 0.037M (4.85 gm/l)4 105.084 0.0624M (8.12 gm/l) 0.058M (7.61 gm/l) 93.78
1 - Added at 33 hours growth.
2 - After an additional 62 hours growth.
3 - Molar Yield = gm L-Leucine x 100 grfl Na a-Ketoisocaproic Acid
4 - Analytical error on HPLC assays is approximately +10E, suggesting that this number is an analytical error on
the high side.
Example 4
The seed culture medium and growth medium of Example 3 were used to grow Brevibacterium thiogenitalis ATCC No. 31 723 for the purpose of biotransforming alpha-ketoisovaleric acid to L-valine. Seed cultures and test shake flask cultures were prepared according to the method described in Example 3, using this strain.
An aqueous unpurified 4.53% (wt/wt) solution of Na alpha-ketoisovaleric acid solution was used. The solution was a sodium hydrolyzate of isopropylidenehydantoin prepared according to the method described in Example 1 using a sufficient quantity of the isopropylidenehydantoin to form a 6% solution in water and NaOH prior to boiling A one molar solution of the Na alphaketoisovaleric acid contained about 1.2M NaOH, 0.5M sodium carbonate and 0.5M urea. The solution pH of 13.8 was adjusted to 7.0 with glacial acetic acid. The solution was steam sterilized at 121 C for 15 minutes.
A separate glucose solution (70 /0 wt/vol in deionized water) was prepared and was steam sterilized at 121"C for 15 minutes. Seventy parts of the sterile alpha-ketoisovaleric acid solution were added aseptically to 30 parts of the sterile glucose solution. Volumes of this mixture were added to the test shake flask cultures at various stages of growth such that the final broth concentrations of Na alpha-ketoisovaleric acid was either 10 or 15 gm/l, as shown in Table 4.
The total growth period was 40 hours for each test shake flask culture. At that point, samples were withdrawn, Milli-pore filtered (0.22 p pore size) and analyzed for L-valine using an HPLC assay as in Example 1.
In a control study using the same microorganisms and procedures, Na alpha-ketoisovaleric acid was omitted from the fermentation. The controls produced an average of .0205M (2.4 gm/l) L-valine from glucose. This has not been accounted for in the test results shown in Table 4.
Table 4
Na a-Keto- Time of L-Valine Molar
isovaleric Acid Addition Produced Yield2
0.0725M 16 hrs .0846 + .008M
(10 gm/l) (9.90 + 0.90 gm/l) 998 0.0725M 24 hrs .0910 + .003M
(10 gm/l) (10.65 + 0.35 gm/l) 3 10663 0.1087M 16 hrs .1004 + .005M
(15 gm/l) (11.75 + 0.55 gm/l) 78%
1 - After 40 hours total growth period.
2 - Molar Yield = gm L-Valine x 100
gm Na a-ketoisovaleric Acid
3 - Analytical error on HPLC assays is approximately +10t, suggesting that this number is an analytical error on
the high side.
Example 5
This Example compares the biotransformation efficiency of Brevibacterium thiogenitalis ATCC
No. 31723 when fed with a KOH 5-benzylidenehydantoin hydrolyzate (K phenylpyruvic acid) and when fed with a 98% pure Na Phenylpyruvic acid. The alpha-keto acid solutions were prepared as follows:
K Phenylpyruvic Acid--An unpurified KOH hydrolyzate of 5-benzylidenehydantoin (obtained from Hampshire Chemical) was prepared as in Example 1 from 3M KOH per mole 5benzylidenehydantoin The pH of the hydrolyzate was adjusted to 8.0 with CO2 gas prior to feeding the shake flasks.
Na Phenylpyruvic Acids solid Na phenylpyruvate monohydrate (98%) (obtained from
Aldrich Chemical Co.) was dissolved in 0.6M aqueous KOH to a concentration of 98 gm/l (as
Na phenylpyruvate monohydrate (Na PPa H20). The pH was adjusted to 8.0 with CO2 gas prior to feeding the shake flasks.
The seed and growth media used were prepared as described in Example 1, except that the
MOPS buffer was replaced with 20 gm/l CaCO3 and the glucose plus other media components were autoclaved together for 10 minutes at 110"C (instead of separate steam sterilization). Seed cultures were prepared as in Example 1, using Brevibacterium thiogenitalis ATCC No. 31 723.
The seed cultures were used to inoculate shake flasks as described in Example 1. After an initial 1 7 hour growth period, separate shake flasks were fed with the phenylpyruvic acid solutions in amounts such that the final culture broth concentrations of phenylpyruvate were 76.22 mM (12.51 gm/i as phenylpyruvic acid). The shake flasks were allowed to grow, and molar yields were determined at 23 hours (40 hours total growth) and at 28 hours (45 hours total growth). HPLC assays were done as in Example 1. The results. shown in Table 5, indicate that the ability of Brevibacterium thiogenitalis ATCC No. 31 723 to biotransform phenylpyruvate to L-phenylalanine is not fully realized when impure precursor is used in this process.
Table 5
Phenylpyruvate L-Phenylalanine Production (mM) Molar Molar
23 Hrs Yield 28 Hrs Yield K phenyl- 35.96 # .85 47.2 # 1.1 49.52 # 12.7 65 # 16.7
pyruvate
Na phenyl- 67.80 + 0 89.0 + 0 69.19 + 1.2 90.8 + 1.6
pyruvate 1 - Duplicate shake flask tests.
2 - Time from addition of phenylpyruvate.
3 - Molar yield = mM L-Phenylalanine x 100
mM Phenylpyruvate
Example 6
This Example was conducted using sodium phenylpyruvic acid (Na-PPA) purified by precipitation from a sodium hydroxide hydrolyzate of 5-benzylidenehydantoin. The hydrolyzate was prepared according to the method of Example 1.
An acetic acid precipitate was then prepared from the hydrolyzate. A 1 500 ml volume of hydrolyzate was placed in a 200 cc glass beaker, in an ice water bath. Glacial acetic acid (conc.
99.7%, 17.4M) was added gradually while stirring to lower the pH to 9. The temperature was not allowed to rise above 30 C. Precipitate began to form at about pH 12.95; after 15 minutes, the pH had reached 9.
The mixture was allowed to stand, covered and under a hood, for 1 hour at 23 C. The slurry was filtered through #4 Whatman paper, without washing. The wet precipitate was placed in a vacuum oven at 50 C for 18 hours. The dry precipitate was put through a #40 mesh sieve. The final product was 79% pure Na-PPa-H2O, with other components including acetate, Na+ and small amounts of CD3-- and organic nitrogen.
Seed and growth culture media were prepared as described in Example 5. Brevibacterium thiogenitalis ATCC No. 31723 was grown on the seed medium as in Example 5. The seed culture was used to inoculate 250 cc shake flasks.
After an initial 18 hour growth period, the precipitated Na-PPA-H20) was redissolved in 0.3M
KOH (100 gm/l as Na-PPA-H20) was added to the shake flasks to achieve the final broth concentrations indicated in Table 6. The cultures were allowed to grow for an additional 23 hour period. HPLC assays for L-phenylalanine were done as described in Example 1. The results are shown in Table 6. The results are approximate as the evaporative loss of liquid from the shake flasks was not measured.
Table 6
Growth at 23 hrs. Molar4
Test No. Na-PPA-H2O L-Phenylalanine (O.D.) 640 nm) Yield 1 0 0 34 # 4 2 1.73 # .12 1,8 # .09 41 # 2 100 3 3.06 # 0 3.69 # .02 40 # 2 100 4 3.3 # .08 3.57 # .19 24 # 1 100 5 5.71 # 0 6.32 # .19 27 # 1 100 6 5.75 # .36 6.18 # .11 23 # 0 100 7 6.80 # .05 6.05 # .05 43 # 2 88 8 8.16 # .44 7.4 # 0 43 # 0 90 9 9.13 # .36 6.99 # .14 27 # 0 76 10 9.45 # 0 8.35 # .15 36 # 7 88 11 9.49 # 0 7.82 # .12 24 # 1 82 12 12.91 # .04 10.05 # .95 37 # 5 78 Duplicate shake flask experiments.
Colorimetrically assayed PPA concentration in the medium (gm/l).
Concentration of L-Phenylalanine (gm/l) produced in 23 hours.
M L-phenylalanine 4 Molar yield = x 100.
M Phenylpyruvate
Claims (12)
1. A process for the preparation of L-amino acid comprising:
(a) growing microorganisms which are capable of transforming an alpha-keto acid into the
corresponding L-amino acid, in a nutrient medium,
(b) feeding the desired alpha-keto acid to the logarithmically growing microorganisms, and
(c) allowing the growing microorganisms to convert said alpha-keto acid to the corresponding
L-amino acid
2.A process for the biological transamination of an aklpha-keto acid to the corresponding Lamino acid using the coupled enzyme system of a logarithmically growing bacterial culture which comprises:
(a) contacting a logarithmicaily growing culture of microorganisms capable of transforming
alpha-keto acids into the corresponding L-amino acids with the desired alpha-keto acid in
the presence of a nutrient medium, and
(b) allowing the coupled enzyme system of said growing culture to drive the alpha-keto acid
to L-arnino acid transamination reaction.
3. The process of Claim 1 or 2 in which said microorganisms substantially comprise a single bacterial strain.
4. The process of Claim 1 or 2 in which said microorganisms are selected from the group comprising glutamic acid excreting bacteria and Eschenchia coli
5. The process of Claim 4 in which said glutamic acid producing excreting bacteria are
elected from the group comprising Rrevibacteriurn species and Corynebacterium species.
.). rl.e process of any of Claims 1 to 5 in which the L-amino acid is recovered from the culture medium.
7. The process of any of Claims 1 to 6 in which the microorganisms are grown for about 6 to about 40 hours before addition of the alpha-keto acid and for from about 20 to 72 hours while the alpha-keto acid is fed thereto.
8. The process of any of Claims 1 to 7 in which said alpha-keto acid is present in the amount of about 0.5% (wt/vol) to about 5.0 M0 (wt/vol) in the culture broth.
9. The process of any of Claims 1 to 8 in which said alpha-keto acid is present in an aqueous solution.
10. The process of Claim 9 in which the concentration of said aqueous solution is from about 1.0% (wt/vol) to about 20% (wt/vol).
11. The process of any of Claims 1 to 10 in which the said alpha-keto acid is phenylpyruvic acid, alpha-ketoisocaproic acid, alpha-ketoisovaleric acid, pyruvic acid, oxaloacetic acid, p- hydroxy-alpha-ketobutyric acid, p-oxyphenyl pyruvic acid, indole pyruvic acid or alpha-keto-ss- methylvaleric acid.
1 2. The process of Claim 1 or 2 substantially as hereinbefore described.
1 3. L-amino acid prepared by
(a) culturing in nutrient medium microorganisms capable of transforming a precursor alpha
keto acid to the desired L-amino acid,
(b) causing the culture to be in an actively, logarithmically growing phase,
(c) contacting the logarithmically growing culture with some precursor alpha-keto acid, and
(d) allowing said growing culture to convert the alpha-keto acid to the corresponding L-amino
acid.
1 4. The L-amino acid of Claim 1 3 which has been recovered from the culture medium.
1 5. The L-amino acid of Claim 1 3 or 1 4 which is prepared from a precursor alpha-keto acid selected from phenylpyruvic acid, alpha-ketoisocaproic acid, alpha-ketoisovaleric acid, pyruvic acid, oxaloacetic acid, p-hydrnxyl-alpha-ketobutyric acid, p-oxyphenyl pyruvic acid, indole pyruvic acid and alpha-keto-ss-methyEvaleric acid.
1 6. L-amino acid produced according to the process of any Claims 1 to
1 2.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52063283A | 1983-08-05 | 1983-08-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB8419142D0 GB8419142D0 (en) | 1984-08-30 |
| GB2147579A true GB2147579A (en) | 1985-05-15 |
Family
ID=24073432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08419142A Withdrawn GB2147579A (en) | 1983-08-05 | 1984-07-27 | Production of L-amino acids from alpha-keto acids by fermentation |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS6043390A (en) |
| AU (1) | AU3040784A (en) |
| DE (1) | DE3427495A1 (en) |
| FR (1) | FR2550801A1 (en) |
| GB (1) | GB2147579A (en) |
| IT (1) | IT1176404B (en) |
| NL (1) | NL8401049A (en) |
| SE (1) | SE8403933L (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200326A (en) * | 1986-05-02 | 1993-04-06 | Degussa Ag | Method for the fermentative production of L-amino acids from α-keto acids |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3423936A1 (en) * | 1984-06-29 | 1986-01-02 | Hoechst Ag, 6230 Frankfurt | METHOD FOR PRODUCING L-PHENYLALANINE |
| JPS6236196A (en) * | 1985-04-15 | 1987-02-17 | Ajinomoto Co Inc | Production of alanine |
| JPS62151191A (en) * | 1985-09-09 | 1987-07-06 | Kuraray Co Ltd | Production of l-phenylalanine |
| JPS6261594A (en) * | 1985-09-11 | 1987-03-18 | Kuraray Co Ltd | Production of l-phenylalanine |
| DE3533198A1 (en) * | 1985-09-18 | 1987-03-19 | Kernforschungsanlage Juelich | METHOD FOR THE FERMENTATIVE PRODUCTION OF L-AMINO ACIDS FROM (ALPHA) KETOCARBOXYL ACIDS |
| JPH0785718B2 (en) * | 1986-03-07 | 1995-09-20 | ダイセル化学工業株式会社 | Method for producing D-amino acid |
| DE3613952A1 (en) * | 1986-04-24 | 1987-10-29 | Hoechst Ag | METHOD FOR PRODUCING L-AMINO ACIDS BY TRANSAMINATION |
| DE3721838A1 (en) * | 1987-07-02 | 1989-01-12 | Hoechst Ag | METHOD FOR PRODUCING L-PHENYLALANINE FROM BENZYLIDENE HYDANTOINE |
| JPH01305589A (en) * | 1988-06-03 | 1989-12-08 | Hitachi Ltd | Electrode wiring processing method |
| CA2008702A1 (en) * | 1989-02-27 | 1990-08-27 | Ronald L. Hanson | Process for transformation of hydroxyketo acids to hydroxyamino acids |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB842679A (en) * | 1957-06-27 | 1960-07-27 | Int Minerals & Chem Corp | Process for producing l-glutamic acid |
| GB903312A (en) * | 1959-03-17 | 1962-08-15 | Ajinomoto Kk | Improvements in or relating to the production of l-tryptophan |
| GB1190546A (en) * | 1968-03-09 | 1970-05-06 | Kyowa Hakko Kogyo Kk | Process for producing L-Threonine and L-Valine |
| GB1265773A (en) * | 1969-08-16 | 1972-03-08 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3183170A (en) * | 1961-10-03 | 1965-05-11 | Sanraku Ocean Kabushiki Kaisha | Method of l-amino acid manufacture |
| US3502544A (en) * | 1966-10-31 | 1970-03-24 | Noda Inst For Scientific Res | Process for producing l-isoleucine by fermentation |
| GB2084155B (en) * | 1980-09-17 | 1984-01-11 | Grace W R & Co | Process for production of l-amino acids using immobilized microorganisms |
| NL8401255A (en) * | 1983-08-05 | 1985-03-01 | Grace W R & Co | PROCESS FOR THE ORGANIC PREPARATION OF L-AMINO ACIDS. |
-
1984
- 1984-04-03 NL NL8401049A patent/NL8401049A/en not_active Application Discontinuation
- 1984-06-14 JP JP59120869A patent/JPS6043390A/en active Pending
- 1984-07-09 AU AU30407/84A patent/AU3040784A/en not_active Abandoned
- 1984-07-17 IT IT21921/84A patent/IT1176404B/en active
- 1984-07-26 DE DE19843427495 patent/DE3427495A1/en not_active Withdrawn
- 1984-07-27 GB GB08419142A patent/GB2147579A/en not_active Withdrawn
- 1984-07-31 SE SE8403933A patent/SE8403933L/en not_active Application Discontinuation
- 1984-08-03 FR FR8412354A patent/FR2550801A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB842679A (en) * | 1957-06-27 | 1960-07-27 | Int Minerals & Chem Corp | Process for producing l-glutamic acid |
| GB903312A (en) * | 1959-03-17 | 1962-08-15 | Ajinomoto Kk | Improvements in or relating to the production of l-tryptophan |
| GB1190546A (en) * | 1968-03-09 | 1970-05-06 | Kyowa Hakko Kogyo Kk | Process for producing L-Threonine and L-Valine |
| GB1265773A (en) * | 1969-08-16 | 1972-03-08 |
Non-Patent Citations (1)
| Title |
|---|
| KIRK OTHMER'S ENCYCLOPAEDIA OF CHEMICAL TECHNOLOGY, 4TH EDITION, VOLUME 9, PAGE 875 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200326A (en) * | 1986-05-02 | 1993-04-06 | Degussa Ag | Method for the fermentative production of L-amino acids from α-keto acids |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6043390A (en) | 1985-03-07 |
| SE8403933L (en) | 1985-02-06 |
| NL8401049A (en) | 1985-03-01 |
| IT8421921A0 (en) | 1984-07-17 |
| DE3427495A1 (en) | 1985-02-14 |
| IT1176404B (en) | 1987-08-18 |
| SE8403933D0 (en) | 1984-07-31 |
| FR2550801A1 (en) | 1985-02-22 |
| GB8419142D0 (en) | 1984-08-30 |
| AU3040784A (en) | 1985-02-07 |
| IT8421921A1 (en) | 1986-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU656416B2 (en) | A process for the fermentative preparation of amino acids | |
| US5919670A (en) | Process for producing L-amino acids by fermentation | |
| GB2147579A (en) | Production of L-amino acids from alpha-keto acids by fermentation | |
| US3909353A (en) | Method of producing L-phenylalanine by fermentation | |
| JPS62195293A (en) | Production of l-isoleucine by fermentation method | |
| US4745059A (en) | Process for the preparation of L-phenylalanine | |
| US4584273A (en) | Method for the production of phenylalanine ammonia-lyase by fermentation | |
| GB2147580A (en) | Improved process for producing L-amino acids from alpha-keto acids by fed-batch fermentation | |
| EP0140503A1 (en) | An efficient process for preparing L-amino acids in bacteria | |
| US4368266A (en) | Method for producing L-glutamic acid by fermentation | |
| JP3074781B2 (en) | Production method of L-lysine by fermentation method | |
| JPS62289192A (en) | Continuous production of amino acid by fermentation | |
| EP0295622B1 (en) | Process for producing l-tryptophan | |
| US5034319A (en) | Process for producing L-arginine | |
| JP3006907B2 (en) | Method for producing L-alanine by fermentation method | |
| JP3029868B2 (en) | Method for producing L-alanine by fermentation method | |
| JP3100763B2 (en) | Method for producing L-arginine by fermentation | |
| US5118619A (en) | Method for the fermentative production of L-isoleucine from D,L-α-hydroxybutyrate | |
| JPH03236786A (en) | Production of l-threonine by fermentation method | |
| US5478733A (en) | Process for producing L-alanine by fermentation with arthrobacter | |
| JPH0253494A (en) | Production of d-glutamic acid | |
| Wandrey | Synthesis of L-amino acids by isolated enzymes and microorganisms | |
| JPS60256393A (en) | Fermentative production of branched fat or aromatic l-amino acid | |
| JPH0716428B2 (en) | Method for producing L-amino acid | |
| JPH09271382A (en) | Method for producing L-amino acid by fermentation using ectoin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |